A. Imada

Publication List Details

Period

1984 - 2009

Number

30

Co-Authors

Early phase observations of extremely luminous Type Ia Supernova 2009dc (2009)

Yamanaka, M., Kawabata, K. S., Kinugasa, K., Tanaka, M., Imada, A., Maeda, K., ...

We present early phase observations in optical and near-infrared wavelengths for the extremely luminous Type Ia supernova (SN Ia) 2009dc. The decline rate of the light curve is $\Delta...

Spectroscopic Observations of WZ Sge-type Dwarf Novae, GW Lib and V455 And in Superoutburst (2008)

Nogami, D., Hiroi, K., Suzuki, Y., Moritani, Y., Soejima, Y., Imada, A., ...

We carried out intensive spectroscopic observations of two WZ Sge-type dwarf novae, GW Lib, and V455 And during their superoutbursts in 2007, at 6 observatories. The observations covered the whole of...

Discovery of a WZ Sge-Type Dwarf Nova, SDSS J102146.44+234926.3: Unprecedented Infrared Activity during a Rebrightening Phase (2007)

Uemura, M., Arai, A., Krajci, T., Pavlenko, E., Shugarov, S. Yu., Katysheva, N. A., ...

Several SU UMa-type dwarf novae, in particular, WZ Sge-type stars tend to exhibit rebrightenings after superoutbursts. The rebrightening phenomenon is problematic for the disk instability theory of...

TV Corvi Revisited: Precursor and Superhump Period Derivative Linked to the Disk Instability Model (2004)

Uemura, M., Mennickent, R. E., Ishioka, R., Imada, A., Kato, T., Nogami, D., ...

We report optical photometric observations of four superoutbursts of the short-period dwarf nova TV Crv. This object experiences two types of superoutbursts; one with a precursor and the other...

The Peculiar 2004 Superoutburst in the Helium Dwarf Nova, 2003aw (2004)

Nogami, D., Monard, B., Retter, A., Liu, A., Uemura, M., Ishioka, R., ...

We conducted a time-resolved photometric campaign of the helium dwarf nova, 2003aw in 2004 May--June. 2003aw stayed at 14.7--15.7 mag for the first several days during this campaign, which is the...

Treatment of dialysis-induced hypotension with L-threo-3,4-dihydroxyphenylserine (1994)

Iida, N., Tsubakihara, Y., Shirai, D., Imada, A., Suzuki, M.

L-threo-3,4-dihydroxyphenylserine (L DOPS), a precursor of noradrenaline (norepinephrine), which is converted into noradrenaline when orally administered, was given orally to haemodialysed patients...

Optimization of permanent linear wiggler for free electron laser by using the 3-D finite element method (1987)

Nakata, Takayoshi, Takahashi, N., Imada, A., Tabauchi, N., Kumada, M.

The optimal configuration of magnets of a linear wiggler, which produces the flux focussing and wiggling of an electron beam, has been investigated in order to improve the performance of a device for...

Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis (1984)

Hasegawa, H., Imada, A., Horiuchi, A., Nishii, Y., Fukushima, M., Kurokawa, E.

The pharmacokinetics of cefotaxime were studied in 13 patients on haemodialysis or continuous ambulatory peritoneal dialysis (CAPD). One gram of cefotaxime was administered intravenously or...

Mechanism of renal excretion of carumonam in rats, rabbits, dogs, and monkeys.

Kita, Y, Imada, A

The mechanism of the renal excretion of carumonam (CRMN) was investigated in rats, rabbits, dogs, and monkeys. Stop-flow analysis in dogs demonstrated that CRMN is exclusively excreted by glomerular...

In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.

Imada, A, Kondo, M, Okonogi, K, Yukishige, K, Kuno, M

The in vitro and in vivo antibacterial activities of carumonam (AMA-1080), a synthetic sulfazecin derivative, were compared with those of aztreonam, cefoperazone, ceftazidime, and cefsulodin....

Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.

Kita, Y, Fugono, T, Imada, A

The pharmacokinetic properties of carumonam (AMA-1080, Ro 17-2301) were studied in mice, rats, rabbits, dogs, and cynomolgus monkeys and compared with those of aztreonam. Carumonam administered...

Novel morphological changes in gram-negative bacteria caused by combination of bulgecin and cefmenoxime.

Nakao, M, Yukishige, K, Kondo, M, Imada, A

The mode of action of bulgecin was investigated by examining its bactericidal and bacteriolytic activities, its effect on bacterial morphology, and its interaction with penicillin-binding proteins...

Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.

Iizawa, Y, Okonogi, K, Hayashi, R, Iwahi, T, Yamazaki, T, Imada, A

The therapeutic effect of cefozopran (SCE-2787), a new semisynthetic parenteral cephalosporin, against experimental infections in mice was examined. Cefozopran was more effective than cefpiramide and...

In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum.

Iwahi, T, Okonogi, K, Yamazaki, T, Shiki, S, Kondo, M, Miyake, A, ...

SCE-2787, a new cephalosporin having a condensed azolium moiety in the 3 position and an aminothiadiazolyl group in the 7 beta side chain, was evaluated for its in vitro and in vivo activities in...

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.

Iwahi, T, Satoh, H, Nakao, M, Iwasaki, T, Yamazaki, T, Kubo, K, ...

The activities of various types of antiulcer agents against Helicobacter pylori (formerly called Campylobacter pylori) strains were determined by an agar dilution method. Among the compounds tested,...

Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.

Iizawa, Y, Nishi, T, Kondo, M, Tsuchiya, K, Imada, A

The effect of recombinant human interleukin-2 (rIL-2) on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice was examined. rIL-2 was administered...

Interaction of Escherichia coli with polymorphonuclear leukocytes in pathogenesis of urinary tract infection in mice.

Iwahi, T, Imada, A

Two type 1 fimbria-producing strains of Escherichia coli, 31-B and K12W1-3, and two type 1 fimbriae-defective mutants derived from 31-B, BH5 and BH9, were compared for their capacity to induce...

Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals.

Kita, Y, Yamazaki, T, Imada, A

The pharmacokinetic properties of SCE-2787 administered intravenously at a dose of 20 mg/kg of body weight were studied with mice, rats, rabbits, dogs, and monkeys and were compared with those of...

Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice.

Iwahi, T, Abe, Y, Nakao, M, Imada, A, Tsuchiya, K

Escherichia coli mutants defective in the ability to agglutinate guinea pig erythrocytes (HA-) were isolated from a nalidixic acid-resistant derivative, 31-B, of E. coli TN 675 that produces type 1...

Mechanism of renal excretion of carumonam in rats, rabbits, dogs, and monkeys.

Kita, Y, Imada, A

The mechanism of the renal excretion of carumonam (CRMN) was investigated in rats, rabbits, dogs, and monkeys. Stop-flow analysis in dogs demonstrated that CRMN is exclusively excreted by glomerular...

In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.

Imada, A, Kondo, M, Okonogi, K, Yukishige, K, Kuno, M

The in vitro and in vivo antibacterial activities of carumonam (AMA-1080), a synthetic sulfazecin derivative, were compared with those of aztreonam, cefoperazone, ceftazidime, and cefsulodin....

Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.

Kita, Y, Fugono, T, Imada, A

The pharmacokinetic properties of carumonam (AMA-1080, Ro 17-2301) were studied in mice, rats, rabbits, dogs, and cynomolgus monkeys and compared with those of aztreonam. Carumonam administered...

Novel morphological changes in gram-negative bacteria caused by combination of bulgecin and cefmenoxime.

Nakao, M, Yukishige, K, Kondo, M, Imada, A

The mode of action of bulgecin was investigated by examining its bactericidal and bacteriolytic activities, its effect on bacterial morphology, and its interaction with penicillin-binding proteins...

Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.

Iizawa, Y, Okonogi, K, Hayashi, R, Iwahi, T, Yamazaki, T, Imada, A

The therapeutic effect of cefozopran (SCE-2787), a new semisynthetic parenteral cephalosporin, against experimental infections in mice was examined. Cefozopran was more effective than cefpiramide and...

In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum.

Iwahi, T, Okonogi, K, Yamazaki, T, Shiki, S, Kondo, M, Miyake, A, ...

SCE-2787, a new cephalosporin having a condensed azolium moiety in the 3 position and an aminothiadiazolyl group in the 7 beta side chain, was evaluated for its in vitro and in vivo activities in...

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.

Iwahi, T, Satoh, H, Nakao, M, Iwasaki, T, Yamazaki, T, Kubo, K, ...

The activities of various types of antiulcer agents against Helicobacter pylori (formerly called Campylobacter pylori) strains were determined by an agar dilution method. Among the compounds tested,...

Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.

Iizawa, Y, Nishi, T, Kondo, M, Tsuchiya, K, Imada, A

The effect of recombinant human interleukin-2 (rIL-2) on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice was examined. rIL-2 was administered...

Interaction of Escherichia coli with polymorphonuclear leukocytes in pathogenesis of urinary tract infection in mice.

Iwahi, T, Imada, A

Two type 1 fimbria-producing strains of Escherichia coli, 31-B and K12W1-3, and two type 1 fimbriae-defective mutants derived from 31-B, BH5 and BH9, were compared for their capacity to induce...

Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals.

Kita, Y, Yamazaki, T, Imada, A

The pharmacokinetic properties of SCE-2787 administered intravenously at a dose of 20 mg/kg of body weight were studied with mice, rats, rabbits, dogs, and monkeys and were compared with those of...

Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice.

Iwahi, T, Abe, Y, Nakao, M, Imada, A, Tsuchiya, K

Escherichia coli mutants defective in the ability to agglutinate guinea pig erythrocytes (HA-) were isolated from a nalidixic acid-resistant derivative, 31-B, of E. coli TN 675 that produces type 1...